|
1 Company |
|
2 Products |
|
2 Products |
|
8 Mechanisms of Action |
|
0 Trials |
|
17 News |
|
- | Trial completion, Trial completion date: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Nov 13, 2018
P=N/A, N=4150, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed | Trial completion date: Apr 2014 --> Oct 2018
- | vigabatrin / Generic mfg.
Trial completion: SoluWest: Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy (clinicaltrials.gov) - Apr 24, 2018
P=N/A, N=38, Completed, Sponsor: Targeon SAS
Active, not recruiting --> Completed | Trial completion date: Apr 2014 --> Oct 2018 Recruiting --> Completed
- | Trial completion, Enrollment change: Evaluation of Neuroinflammation in Children With Infantile Spasms (clinicaltrials.gov) - Nov 7, 2017
P4, N=8, Completed, Sponsor: Wayne State University
Recruiting --> Completed Recruiting --> Completed | N=10 --> 8
- ||| vigabatrin / Generic mfg.
Trial completion, Enrollment change: Sabril Patient Registry (clinicaltrials.gov) - Jul 30, 2016
P=N/A, N=9423, Completed, Sponsor: Lundbeck LLC
Recruiting --> Completed | N=10 --> 8 Enrolling by invitation --> Completed | N=15000 --> 9423
- Trial primary completion date: Evaluation of Neuroinflammation in Children With Infantile Spasms (clinicaltrials.gov) - Jan 17, 2016
P4, N=10, Recruiting, Sponsor: Wayne State University
Enrolling by invitation --> Completed | N=15000 --> 9423 Trial primary completion date: Jul 2015 --> Jul 2016
- vigabatrin / Generic mfg.
Clinical: SoluWest: Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=50, Recruiting, Sponsor: Targeon SAS
- New P4 trial: Evaluation of Neuroinflammation in Children With Infantile Spasms (clinicaltrials.gov) - Mar 18, 2014
P4, N=10, Recruiting, Sponsor: Wayne State University
- Enrollment change: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Jan 14, 2014
P=N/A, N=4150, Active, not recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Jul 2015 --> Jul 2016 N=5250 --> 4150
- || New P3 trial: Addition of Pyridoxine to Prednisolone in Infantile Spasms (clinicaltrials.gov) - Apr 8, 2013
P3, N=58, Recruiting, Sponsor: Lady Hardinge Medical College
- Trial withdrawal: Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy (clinicaltrials.gov) - Apr 6, 2013
P2/3, N=0, Withdrawn, Sponsor: Lady Hardinge Medical College
N=5250 --> 4150 Recruiting --> Withdrawn
- Enrollment change: Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy (clinicaltrials.gov) - Apr 6, 2013
P2/3, N=0, Withdrawn, Sponsor: Lady Hardinge Medical College
Recruiting --> Withdrawn N=60 --> 0
- | prednisolone / Generic mfg.
Trial completion: Prednisolone in Infantile Spasms- High Dose Versus Usual Dose (clinicaltrials.gov) - Apr 6, 2013
P3, N=63, Completed, Sponsor: Lady Hardinge Medical College
N=60 --> 0 Recruiting --> Completed
- Enrollment closed: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Dec 12, 2012
P=N/A, N=4150, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Active, not recruiting
- vigabatrin / Generic mfg.
Trial withdrawal: An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms (clinicaltrials.gov) - Sep 11, 2012
P4, N=0, Withdrawn, Sponsor: Lundbeck LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- || prednisolone / Generic mfg.
New P3 trial: Prednisolone in Infantile Spasms- High Dose Versus Usual Dose (clinicaltrials.gov) - Apr 9, 2012
P3, N=63, Completed, Sponsor: Lady Hardinge Medical College
- New P2/3 trial: Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy (clinicaltrials.gov) - Mar 7, 2012
P2/3, N=0, Withdrawn, Sponsor: Lady Hardinge Medical College
- vigabatrin / Generic mfg.
New P4 trial: An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms (clinicaltrials.gov) - Aug 8, 2011
P4, N=0, Withdrawn, Sponsor: Lundbeck LLC